Vaccine manufacturer claims Biden and India at fault for UK delays telegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from telegraph.co.uk Daily Mail and Mail on Sunday newspapers.
Text Size:
A+
New Delhi: Two figures and a looming deadline have raised a question around India’s Covid vaccination drive.
India has administered roughly as many Covid vaccine doses within the country as it has sent for commercial exports. However, even as the earliest batches of the Covid vaccines are set to expire next month, the government refuses to allow domestic commercial sales.
Covishield and Covaxin, the two vaccines being used in India, were granted emergency use authorisation on 3 January. Since 16 January, when the Covid vaccination drive was rolled out in India, 3.48 crore doses have been administered in the country. Meanwhile, India has commercially exported 3.39 crore doses to countries around the world since the first of these batches went out to Morocco and Brazil on 22 January.
India s group that looks at adverse effects is aware of the issue and are tracking the information available, the govt said
NEW DELHI: There is no signal of concern against use of AstraZeneca s Covid vaccine in the country, the Union health ministry assured on Wednesday amid reports of blood clot fears and speculations over its side-effects.
Taking note of nations halting the rollout, the health ministry said, There are reports on AstraZeneca s vaccine relationship with thrombotic events in people who received the vaccine. The European medical agency says it is a precautionary measure and there s no data, assessment being done.
Even as concerns rise across the globe on the safety of the AstraZeneca-Oxford vaccine, India has found it safe, saying the nationwide inoculation drive can continue. The AstraZeneca-Oxford vaccine called Covishield in India is manufactured in the country by Pune-based Serum Institute of India, the world’s largest vaccine maker by volume. A senior member of the national Adverse Events Following Immunisation (AEFI) committee said that of the 38 autopsy reports they have studied of people who died after vaccination, they found nothing to link the deaths or adverse events to vaccination. “There are 71 deaths. We have received 38 autopsy reports so far. There is nothing to suggest that these were linked to vaccination,” said the person who has been a part of the AEFI committee since 2008.
Reasons behind Maharashtra s poor Covid showing Maharashtra s poor show in curbing the spread of the coronavirus is because it is not testing enough and properly, a report in
ThePrint said. The state has 56 per cent of the active caseload in India, but it accounts for just seven per cent of fully vaccinated people in the country. Also, despite the fact that the state is now close to testing 100,000 samples a day, the tests-per-million metric is at 1,42,513.9 against a national average of 1,63,160, the report said. Read more here
Cases of seasonal flu dip amid Covid Cases of seasonal flu a common occurrence in January and February have seen a dip amid the Covid-19 pandemic, a report in ThePrint said. Sales of medication for cold and flu declined by 14 per cent from Rs 3,154 crore to Rs 2,712 crore between February 2020 and February 2021, according to data gathered by the All India Organisation of Chemist and Druggist (AIOCD-AWACS). Experts say compliance with recommended preca